ONTARIO, CA / ACCESS Newswire / January 29, 2025 / Focus Universal inc. (Nasdaq:FCUV) ("Focus" or the "Company"), a provider ...
Hosted on MSN1d
REVB Start 1B Trial and Announces SplitREVB READ THE FULL REVB RESEARCH REPORT Revelation Biosciences (NASDAQ:REVB) announced that it has initiated its US based Phase 1b clinical study to evaluate the potential of Gemini as a ...
WASHINGTON - 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW), a company specializing in the development of treatments ...
Eyenovia, Inc. (NASDAQ: EYEN) ("Eyenovia" or the "Company"), an ophthalmic technology company focused on completing development of its proprietary Optejet ...
(NASDAQ: EYEN) (“Eyenovia” or the “Company”), an ophthalmic technology company focused on completing development of its proprietary Optejet topical ophthalmic medication dispensing platform, today ...
The company has already cut its workforce, seen a leadership change and agreed to be acquired. Here's what's next.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback